Novo Nordisk
NVO
#81
Rank
C$285.38 B
Marketcap
C$64.23
Share price
-0.88%
Change (1 day)
-58.54%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): C$29.32 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are C$47.21 Billion. In 2024 the company made an earning of C$26.21 Billion, an increase over its 2023 earnings that were of C$21.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$29.32 B11.84%
2024 C$26.21 B22.84%
2023 C$21.34 B57.81%
2022 C$13.52 B5.24%
2021 C$12.85 B12.38%
2020 C$11.43 B13.11%
2019 C$10.11 B-3.45%
2018 C$10.47 B1.88%
2017 C$10.27 B4.3%
2016 C$9.85 B10.32%
2015 C$8.93 B7.47%
2014 C$8.31 B3.4%
2013 C$8.03 B19.09%
2012 C$6.75 B15.58%
2011 C$5.84 B16.58%
2010 C$5.00 B25.66%
2009 C$3.98 B10.68%
2008 C$3.60 B55.82%
2007 C$2.31 B7.02%
2006 C$2.16 B19.05%
2005 C$1.81 B10.55%
2004 C$1.64 B
2002 C$1.12 B-14.39%
2001 C$1.31 B-52.82%
2000 C$2.78 B250%
1999 C$0.79 B31.21%
1998 C$0.60 B34.31%
1997 C$0.45 B11.46%
1996 C$0.40 B9.03%
1995 C$0.37 B-3.15%
1994 C$0.38 B-0.67%
1993 C$0.38 B45.38%
1992 C$0.26 B-13.81%
1991 C$0.30 B37.12%
1990 C$0.22 B-0.79%
1989 C$0.22 B26.2%
1988 C$0.17 B24.97%
1987 C$0.14 B-0.9%
1986 C$0.14 B-7.78%
1985 C$0.15 B24.87%
1984 C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.41 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.17 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.12 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.60 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France